Regulation of Inflammatory Reaction in Health and Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Jun 2

PMID 34067872

Citations 24

Authors

Massimo Fioranelli

Maria Grazia Roccia

Dana Flavin

Linda Cota

Affiliations

Soon will be listed here.

Abstract

Inflammation is a key mechanism for the clearance of infective agents and other inflammatory triggers and is pivotal for the repairing processes of the affected tissues. Inflammation is a multistep process driven by a great number of mediators which regulate specific aspects of the inflammatory response, in agreement with a well-defined chronobiological program. A great number of inflammation-related diseases show a deeply altered immune chronobiology (e.g., COVID-19-related cytokines storm). This aspect highlights the need for a deeper understanding of the inflammatory phenomenon. It is fundamental to study inflammation as a multilevel phenomenon. Of particular interest is the low-grade chronic inflammation, which is an etiological factor of many chronic diseases. Nowadays, the therapeutic approach to low grade chronic inflammation is one of the great challenges of traditional pharmacology. Currently, no drugs specifically designed for the treatment of chronic inflammatory forms are available. Today, bioregulatory systems medicine (BrSM) and low dose medicine (LDM), two pharmacological paradigms grounded in systems medicine, potentially represent new tools for the treatment of inflammation-related diseases. Scientific research has assessed the effectiveness and safety of both these therapeutic approaches, in particular for the management of chronic inflammatory conditions and chronic immunological dysregulations.

Citing Articles

Glabridin Suppresses Macrophage Activation by Lipoteichoic Acid In Vitro: The Crucial Role of MAPKs-IL-1β-iNOS Axis Signals in Peritoneal and Alveolar Macrophages.

Hou S, Yang C, Huang W, Cheng S, Yen T, Hsia C Biomolecules. 2025; 15(2).

PMID: 40001477 PMC: 11853366. DOI: 10.3390/biom15020174.

: Pharmacological potential revealed by phytochemical and in silico investigations.

Naji Bin-Asal F, Saeed A, Alawi Bin Yahia A Biochem Biophys Rep. 2025; 41:101940.

PMID: 39995632 PMC: 11848803. DOI: 10.1016/j.bbrep.2025.101940.

Effects of Extracts on Obesity and Anxiety.

Kim J, Park J, Baek S, Won S, Cho J Clin Nutr Res. 2025; 14(1):65-77.

PMID: 39968272 PMC: 11832291. DOI: 10.7762/cnr.2025.14.1.65.

Mango Consumption Is Associated with Increased Insulin Sensitivity in Participants with Overweight/Obesity and Chronic Low-Grade Inflammation.

Pett K, Alex P, Weisfuss C, Sandhu A, Burton-Freeman B, Edirisinghe I Nutrients. 2025; 17(3).

PMID: 39940348 PMC: 11820656. DOI: 10.3390/nu17030490.

Quantitative Analysis of Flavonoids and Coumarins from Fingered Citron in Different Growth Periods and Their Regulatory Effects on Oxidative Stress.

Tan T, Xu M, Hong X, Li Z, Li J, Jiao B Foods. 2025; 14(2.

PMID: 39856847 PMC: 11765496. DOI: 10.3390/foods14020180.

References

Barbarroja N, Lopez-Pedrera C, Garrido-Sanchez L, Mayas M, Oliva-Olivera W, Bernal-Lopez M . Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation. PLoS One. 2012; 7(10):e48155. PMC: 3480488. DOI: 10.1371/journal.pone.0048155. View

Su D, Li Z, Li X, Chen Y, Zhang Y, Ding D . Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease. Mediators Inflamm. 2013; 2013:726178. PMC: 3683500. DOI: 10.1155/2013/726178. View

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J . Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018; 9(6):7204-7218. PMC: 5805548. DOI: 10.18632/oncotarget.23208. View

Gariboldi S, Palazzo M, Zanobbio L, Dusio G, Mauro V, Solimene U . Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther. 2009; 22(6):497-510. DOI: 10.1016/j.pupt.2009.05.002. View

Rezus E, Cardoneanu A, Burlui A, Luca A, Codreanu C, Tamba B . The Link Between Inflammaging and Degenerative Joint Diseases. Int J Mol Sci. 2019; 20(3). PMC: 6386892. DOI: 10.3390/ijms20030614. View

Conrad D, Kuhn H, Mulkins M, Highland E, Sigal E . Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A. 1992; 89(1):217-21. PMC: 48207. DOI: 10.1073/pnas.89.1.217. View

Medzhitov R . Origin and physiological roles of inflammation. Nature. 2008; 454(7203):428-35. DOI: 10.1038/nature07201. View

Martin-Martin L, Giovannangeli F, Bizzi E, Massafra U, Ballanti E, Cassol M . An open randomized active-controlled clinical trial with low-dose SKA cytokines versus DMARDs evaluating low disease activity maintenance in patients with rheumatoid arthritis. Drug Des Devel Ther. 2017; 11:985-994. PMC: 5384731. DOI: 10.2147/DDDT.S118298. View

Yan Q . Stress and Systemic Inflammation: Yin-Yang Dynamics in Health and Diseases. Methods Mol Biol. 2018; 1781:3-20. DOI: 10.1007/978-1-4939-7828-1_1. View

10.

Chen Y, Liu S, Leng S . Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation. Clin Ther. 2019; 41(3):400-409. DOI: 10.1016/j.clinthera.2019.02.001. View

11.

Theoharides T, Cholevas C, Polyzoidis K, Politis A . Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors. 2021; 47(2):232-241. PMC: 8250989. DOI: 10.1002/biof.1726. View

12.

Goldman A, Burmeister Y, Cesnulevicius K, Herbert M, Kane M, Lescheid D . Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity?. Front Physiol. 2015; 6:225. PMC: 4541032. DOI: 10.3389/fphys.2015.00225. View

13.

Scott A, Khan K, Cook J, Duronio V . What is "inflammation"? Are we ready to move beyond Celsus?. Br J Sports Med. 2004; 38(3):248-9. PMC: 1724817. DOI: 10.1136/bjsm.2003.011221. View

14.

Dethlefsen C, Hojfeldt G, Hojman P . The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat. 2013; 138(3):657-64. DOI: 10.1007/s10549-013-2488-z. View

15.

Wronski S, Dannenmaier J, Schild S, Macke O, Muller L, Burmeister Y . Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity. PLoS One. 2018; 13(4):e0195822. PMC: 5909611. DOI: 10.1371/journal.pone.0195822. View

16.

Smith B, Lightfoot S, Lerner M, Denson K, Morgan D, Hanas J . Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol. 2008; 18(1):1-10. DOI: 10.1016/j.carpath.2007.07.011. View

17.

Kapai N, Anisimova N, Kiselevskii M, Sitdikova S, Slavetskaya M . Selective cytokine-inducing effects of low dose Echinacea. Bull Exp Biol Med. 2012; 150(6):711-3. DOI: 10.1007/s10517-011-1230-2. View

18.

Basil M, Levy B . Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2015; 16(1):51-67. PMC: 5242505. DOI: 10.1038/nri.2015.4. View

19.

Carello R, Ricottini L, Miranda V, Panei P, Rocchi L, Arcieri R . Long-term treatment with low-dose medicine in chronic childhood eczema: a double-blind two-stage randomized control trial. Ital J Pediatr. 2017; 43(1):78. PMC: 5585968. DOI: 10.1186/s13052-017-0393-5. View

20.

Dobson E, Barrow C, Kralovec J, Adcock J . Controlled formation of mono- and dihydroxy-resolvins from EPA and DHA using soybean 15-lipoxygenase. J Lipid Res. 2013; 54(5):1439-47. PMC: 3622336. DOI: 10.1194/jlr.M036186. View